Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
12/2013
12/11/2013CN102924403B Synthesis method of bismerthiazol
12/10/2013US8604016 Heterocyclic inhibitors of glutaminase
12/05/2013US20130324537 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
12/05/2013DE10216686B4 Verwendung von 2,5-Dimercapto-1,3,4-thiadiazol-Reaktionsprodukten und -Addukten als Additiva in Schmierstoffen Using 2,5-dimercapto-1,3,4-thiadiazole-reaction products and adducts as additives in lubricants
12/04/2013EP2489350B1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/04/2013CN203319907U Device used for pressure reduction of pump and provided with backflow
12/04/2013CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications
12/04/2013CN102516202B N-fluoro-1, 1'-binaphthyl-2, 2'-sulfimide and preparation method thereof
12/04/2013CN102432563B Dihydrazide compounds containing 4-methyl-1,2,3-thiadiazole group, and preparation method and application of dihydrazide compounds
12/04/2013CN101622231B 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
12/03/2013CA2530302C Novel aminobenzophenone compounds
11/2013
11/28/2013US20130317032 Thiazole and thiadiazole compounds for inflammation and immune-related uses
11/27/2013CN103408507A Preparation method for 2-amino-1,3,4-thiadiazole compounds
11/21/2013WO2013172171A1 Cyclic carbodiimide compound, polyester film, back sheet for solar cell module and solar cell module
11/20/2013EP2307387B1 Novel heterocyclyl compounds for treatment of cardiovascular disease
11/20/2013CN103396381A Production method for hydrochlorothiazide
11/20/2013CN103396380A Preparation method of (E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetic aid
11/20/2013CN103396321A Alcohol-soluble conjugate organic micromolecular material for cathode interface of solar cell, and preparation method and purpose thereof
11/19/2013US8586733 Processes and intermediates for making sweet taste enhancers
11/14/2013WO2013167994A1 Compositions and methods for suppression of carbonic anhydrase activity
11/13/2013CN102558094B Method for preparing ceftaroline side-chain acid
11/12/2013CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/07/2013US20130296389 Fungicide Active Substance Combinations
11/05/2013US8575146 Pharmaceutical uses of staurosporine derivatives
10/2013
10/31/2013US20130289028 Heterocyclic fused anthraquinone derivatives, manufacturing method and pharmaceutical composition using thereof
10/30/2013CN102276554B 4-((2-amino-5-sulfydryl-1,3,4-thiadiazole)-methyl)-benzamide derivative as well as preparation method and application thereof
10/29/2013US8569345 Compounds and compositions as LXR modulators
10/29/2013US8568756 Inhibition of quorum sensing-mediated processes in bacteria
10/24/2013US20130281512 Agents for treating disorders involving modulation of ryanodine receptors
10/23/2013EP2652004A2 Fluoro monomers, oligomers, and polymers for inks and organic electronic devices
10/23/2013CN102660017B High-refractivity polyarylenesulfidesulfonamide and preparation method thereof
10/17/2013US20130274283 Premature-termination-codons readthrough compounds
10/16/2013EP2650279A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
10/16/2013EP2649056A1 Novel organic compound and organic light-emitting device including same
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351360A Acylthiourea compound containing 1, 3, 4-thiadiazole group, and preparation method and application thereof
10/16/2013CN102060805B 2-thio-1, 3, 4-thiadiazole-3-yl compound and preparation method thereof
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013US20130267537 Heterocyclic sulfonamides
10/08/2013US8552175 Sulfur transfer reagents for oligonucleotide synthesis
10/08/2013US8552039 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
10/08/2013CA2721222C Fungicidal active compound combinations
10/08/2013CA2593463C [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
10/03/2013WO2013144228A1 Pesticidal methods using heterocyclic compounds and derivatives for combating animal pests
10/03/2013US20130261158 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
10/02/2013EP2643308A1 Process for the preparation of taurolidine and its intermediates thereof
10/02/2013CN102603672B Method for synthesizing tebuthiuron technical material
10/01/2013US8546581 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
10/01/2013US8546563 Compounds which modulate the CB2 receptor
10/01/2013US8546391 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
09/2013
09/25/2013CN103320199A Screen phenol-containing thiadiazole type antioxygen antiwear additive and preparation method thereof
09/25/2013CN103319438A 4-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivative and its preparation method and application
09/25/2013CN103319437A Pleuromutilin derivative with thiadiazole skeleton, as well as preparation method and applications thereof
09/25/2013CN103319436A Preparation, refining method and freeze-drying preparation of injection-grade acetazolamide sodium
09/25/2013CN103319435A Double thiadiazole derivative and preparation method thereof
09/25/2013CN103319378A Zwitterionic organic small molecular solar cell cathode interface material, as well as preparation method and use thereof
09/24/2013US8541453 Modulators of ATP-binding cassette transporters
09/19/2013WO2013137832A1 Myostatin inhibitors
09/18/2013EP2638036A1 Compound for increasing kinase active and application thereof
09/17/2013CA2570903C N-hydroxyamide derivatives and use thereof
09/12/2013WO2013134080A2 Improved method and compound for treatment of menopausal symptoms
09/12/2013WO2013134061A1 Phenicol antibacterials
09/12/2013US20130237700 Process for the preparation of taurolidine and its intermediates thereof
09/12/2013US20130237531 Compounds and methods for kinase modulation, and indications therefor
09/11/2013EP2635280A2 Cytosine deaminase modulators for enhancement of dna transfection
09/11/2013CN103288777A Synthesis method of key intermediate of tebuthiuron, namely 2-methylamino-5-tert-butyl-1, 3, 4-thiadiazole
09/11/2013CN103288776A A synthesis method for 2 - sulfinyl -5 - (trifluoromethyl) - 1,3,4 - thiadiazole compounds
09/11/2013CN103288775A Triazole compound, and preparation method and application thereof
09/05/2013US20130231342 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
09/04/2013CN103275067A Inhibitors of histone deacetylase
09/04/2013CN102503908B Vitamin A acid derivative, preparation method thereof, medicine composition thereof and application thereof to preparation anti-tumor medicine
09/04/2013CN101820761B Compositions and methods for controlling nematodes
09/03/2013US8524750 (Pyrazol-3-yl)-1,3,4-thiadiazol-2-amine and (pyrazol-3-yl)-1,3,4-thiazol-2-amine compounds
09/03/2013US8524748 Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
08/2013
08/29/2013WO2013124413A1 Thiadiazolidinediones as gsk-3 inhibitors
08/29/2013US20130225806 Salts of potassium atp channel openers and uses thereof
08/29/2013US20130225587 Compound for increasing kinase active and application thereof
08/28/2013CN102388028B Compounds having activity against hepatitis virus and use thereof
08/27/2013US8519137 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
08/27/2013US8518979 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
08/22/2013WO2013123349A1 Methods of producing sulfilimine compounds
08/22/2013WO2013123047A1 Electronic devices using organic small molecule semiconducting compounds
08/22/2013US20130217687 Arylsulfonamide ccr3 antagonists
08/21/2013EP2628734A2 5-amino-1,2,4-thiadiazole derivatives
08/21/2013EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
08/21/2013CN1533374B Substitutled cyclohexane-1,4-diamine derivatives
08/20/2013US8513289 P38 kinase inhibiting agents
08/20/2013US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
08/20/2013US8512755 Compact multifunctional ligand to enhance colloidal stability of nanoparticles
08/13/2013US8507538 Selective heterocyclic sphingosine 1 phosphate receptor modulators
08/13/2013US8507474 Anthelmintic agents and their use
08/08/2013US20130203739 Cyclic amide derivative
08/07/2013EP2621278A1 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
08/07/2013CN102329283B Hydrochlorothiazide crystal and candesartan cilexetil hydrochlorothiazide medicinal combination thereof
08/07/2013CN102174030B 5-methyl-1,2,3-thiadiazole-4-formoxyl urea compounds, and preparation method and application thereof
08/06/2013US8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/01/2013WO2013019731A3 Phosphate prodrugs
07/2013
07/31/2013CN103228633A Heterocyclic compounds as DGAT1 inhibitors
07/31/2013CN102026970B Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
07/25/2013WO2013108026A1 Thiadiazolone derivatives useful in the treatment of diabetes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 100